您好,欢迎访问中国农业科学院 机构知识库!

Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1

文献类型: 外文期刊

作者: Khan, Ilyas 1 ; Li, Sunan 1 ; Tao, Lihong 1 ; Wang, Chong 1 ; Ye, Bowei 2 ; Li, Huiyu 2 ; Liu, Xiaoyang 1 ; Ahmad, Iqbal 1 ; Su, Wenqiang 1 ; Zhong, Gongxun 1 ; Wen, Zhiyuan 1 ; Wang, Jinliang 1 ; Hua, Rong-Hong 1 ; Ma, Ao 2 ; Liang, Jie 2 ; Wan, Xiao-Peng 1 ; Bu, Zhi-Gao 1 ; Zheng, Yong-Hui 3 ;

作者机构: 1.Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Anim Dis Control & Prevent, Harbin, Peoples R China

2.Univ Illinois, Ctr Bioinformat & Quantitat Biol, Richard & Loan Hill Dept Biomed Engn, Chicago, IL 60607 USA

3.Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA

期刊名称:NATURE COMMUNICATIONS ( 影响因子:16.6; 五年影响因子:17.0 )

ISSN:

年卷期: 2024 年 15 卷 1 期

页码:

收录情况: SCI

摘要: SARS-CoV-2 and filovirus enter cells via the cell surface angiotensin-converting enzyme 2 (ACE2) or the late-endosome Niemann-Pick C1 (NPC1) as a receptor. Here, we screened 974 natural compounds and identified Tubeimosides I, II, and III as pan-coronavirus and filovirus entry inhibitors that target NPC1. Using in-silico, biochemical, and genomic approaches, we provide evidence that NPC1 also binds SARS-CoV-2 spike (S) protein on the receptor-binding domain (RBD), which is blocked by Tubeimosides. Importantly, NPC1 strongly promotes productive SARS-CoV-2 entry, which we propose is due to its influence on fusion in late endosomes. The Tubeimosides' antiviral activity and NPC1 function are further confirmed by infection with SARS-CoV-2 variants of concern (VOC), SARS-CoV, and MERS-CoV. Thus, NPC1 is a critical entry co-factor for highly pathogenic human coronaviruses (HCoVs) in the late endosomes, and Tubeimosides hold promise as a new countermeasure for these HCoVs and filoviruses.

  • 相关文献
作者其他论文 更多>>